ロード中...
Febuxostat Treatment for Gout: What the Clinician Needs to Know
Febuxostat is a new non-purine based inhibitor of xanthine oxidase that will be a useful addition to the drugs available to treat gout. This short review covers general principles of the management of gout and then focuses on practical aspects and use of febuxostat.
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3383484/ https://ncbi.nlm.nih.gov/pubmed/22870428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X09347037 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|